Pharmacological characterization of seven human histamine H3 receptor isoforms

Meichun Gao,Mabel E Dekker,Rob Leurs,Henry F Vischer,Mabel E. Dekker,Henry F. Vischer
DOI: https://doi.org/10.1016/j.ejphar.2024.176450
IF: 5.195
2024-04-01
European Journal of Pharmacology
Abstract:The histamine H<sub>3</sub> receptor (H<sub>3</sub>R) regulates as a presynaptic G protein-coupled receptor the release of histamine and other neurotransmitters in the brain, and is consequently a potential therapeutic target for neuronal disorders. The human H<sub>3</sub>R encodes for seven splice variants that vary in the length of intracellular loop 3 and/or the C-terminal tail but are all able to induce heterotrimeric G<sub>i</sub> protein signaling. The last two decades H<sub>3</sub>R drug discovery and lead optimization has been exclusively focused on the 445 amino acids-long reference isoform H<sub>3</sub>R-445. In this study, we pharmacologically characterized for the first time all seven H<sub>3</sub>R isoforms by determining their binding affinities for reference histamine H<sub>3</sub> receptor agonists and inverse agonists. The H<sub>3</sub>R-453, H<sub>3</sub>R-415, and H<sub>3</sub>R-413 isoforms display similar binding affinities for all ligands as the H<sub>3</sub>R-445. However, increased agonist binding affinities were observed for the three shorter isoforms H<sub>3</sub>R-329, H<sub>3</sub>R-365, and H<sub>3</sub>R-373, whereas inverse agonists such as the approved anti-narcolepsy drug pitolisant (Wakix®) displayed significantly decreased binding affinities for the latter two isoforms. This opposite change in binding affinity of agonist versus inverse agonists on H<sub>3</sub>R-365 and H<sub>3</sub>R-373 is associated with their higher constitutive activity in a cAMP biosensor assay as compared to the other five isoforms. The observed differences in pharmacology between longer and shorter H<sub>3</sub>R isoforms should be considered in future drug discovery programs.
pharmacology & pharmacy
What problem does this paper attempt to address?